FDA Inspection 727311 — EMD Serono, Inc.

EMD Serono, Inc. — FEI 1220970

The FDA completed an inspection of EMD Serono, Inc. on May 18, 2011 in Boston, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 18, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Boston, MA (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures
890721 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.